Editorials |
From the Unit of Cardiac Physiology, Manchester University, Manchester, UK.
Correspondence to D.A. Eisner, Unit of Cardiac Physiology, 1.524 Stopford Bldg, Manchester University, Oxford Rd, Manchester M13 9PT, UK. E-mail eisner@man.ac.uk
Key Words: heart failure SERCA hyperphosphorylation
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
In heart failure, the amplitude and rate of decay of both contraction and the underlying systolic Ca2+ transient are reduced. A current debate concerns the mechanism of these alterations of calcium handling. One theory invokes decreased activity of the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA)1 while another focuses on alterations in the SR Ca2+ release channel (ryanodine receptor, RyR).2 A significant contribution to this debate is made by Jiang et al3 in this issue of Circulation Research.
Excitation-Contraction Coupling
Calcium that activates contraction comes from two sources: (1) the extracellular fluid, largely via the L-type Ca2+ current (ICa); and (2) the SR, by release through the RyR. Because the latter is generally larger and the amplitude of ICa is not consistently altered in failure (see review4), work has focused on release from the SR. Release occurs via calcium-induced calcium release (CICR) whereby Ca2+ entry increases the probability of opening of a closely apposed RyR (see general reviews5,6). Relaxation requires that [Ca2+]i be lowered by the combined effects of SERCA and Na+-Ca2+ exchange (NCX). The activity of SERCA is depressed by the accessory protein phospholamban and this inhibition is removed by phosphorylation, providing a mechanism whereby sympathetic stimulation can increase SR Ca2+ content and hence Ca2+ release from the SR. Importantly, depression of SERCA activity will not only decrease the amplitude of the Ca2+ transient (by decreasing SR content) but will also directly slow the rate of decay.
Phosphorylation of the RyR
The RyR can be phosphorylated,7 and there is
This article has been cited by other articles:
![]() |
L. M. Blayney, J.-L. Jones, J. Griffiths, and F. A. Lai A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201 Cardiovasc Res, September 2, 2009; (2009) cvp273v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. H. T. Wehrens, S. E. Lehnart, S. Reiken, R. van der Nagel, R. Morales, J. Sun, Z. Cheng, S.-X. Deng, L. J. de Windt, D. W. Landry, et al. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure PNAS, July 5, 2005; 102(27): 9607 - 9612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bers, D. A. Eisner, and H. H. Valdivia Sarcoplasmic Reticulum Ca2+ and Heart Failure: Roles of Diastolic Leak and Ca2+ Transport Circ. Res., September 19, 2003; 93(6): 487 - 490. [Full Text] [PDF] |
||||
![]() |
S. A. Khan, M. W. Skaf, R. W. Harrison, K. Lee, K. M. Minhas, A. Kumar, M. Fradley, A. A. Shoukas, D. E. Berkowitz, and J. M. Hare Nitric Oxide Regulation of Myocardial Contractility and Calcium Cycling: Independent Impact of Neuronal and Endothelial Nitric Oxide Synthases Circ. Res., June 27, 2003; 92(12): 1322 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Brette and C. Orchard T-Tubule Function in Mammalian Cardiac Myocytes Circ. Res., June 13, 2003; 92(11): 1182 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Marks A Guide for the Perplexed: Towards an Understanding of the Molecular Basis of Heart Failure Circulation, March 25, 2003; 107(11): 1456 - 1459. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |